These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 32920333)
41. Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases. Fofanova TY; Petrosino JF; Kellermayer R J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):208-19. PubMed ID: 26308318 [TBL] [Abstract][Full Text] [Related]
42. Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease? Ijssennagger N; van der Meer R; van Mil SWC Trends Mol Med; 2016 Mar; 22(3):190-199. PubMed ID: 26852376 [TBL] [Abstract][Full Text] [Related]
43. Microbiota regulation of inflammatory bowel disease and colorectal cancer. Liu Z; Cao AT; Cong Y Semin Cancer Biol; 2013 Dec; 23(6 Pt B):543-52. PubMed ID: 24071482 [TBL] [Abstract][Full Text] [Related]
44. Mucosal immune responses to fungi and the implications for inflammatory bowel disease. Limon JJ; Kershaw KM; Underhill DM Curr Opin Gastroenterol; 2018 Nov; 34(6):398-403. PubMed ID: 30299290 [TBL] [Abstract][Full Text] [Related]
45. Gut biofilm forming bacteria in inflammatory bowel disease. Srivastava A; Gupta J; Kumar S; Kumar A Microb Pathog; 2017 Nov; 112():5-14. PubMed ID: 28942174 [TBL] [Abstract][Full Text] [Related]
46. Cosmc is an X-linked inflammatory bowel disease risk gene that spatially regulates gut microbiota and contributes to sex-specific risk. Kudelka MR; Hinrichs BH; Darby T; Moreno CS; Nishio H; Cutler CE; Wang J; Wu H; Zeng J; Wang Y; Ju T; Stowell SR; Nusrat A; Jones RM; Neish AS; Cummings RD Proc Natl Acad Sci U S A; 2016 Dec; 113(51):14787-14792. PubMed ID: 27930307 [TBL] [Abstract][Full Text] [Related]
47. Specific changes of enteric mycobiota and virome in inflammatory bowel disease. Chu Y; Jiang MZ; Xu B; Wang WJ; Chen D; Li XW; Zhang YJ; Liang J J Dig Dis; 2018 Jan; 19(1):2-7. PubMed ID: 29266753 [TBL] [Abstract][Full Text] [Related]
48. T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome. Larmonier CB; Shehab KW; Ghishan FK; Kiela PR Biomed Res Int; 2015; 2015():504638. PubMed ID: 26583115 [TBL] [Abstract][Full Text] [Related]
49. The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease. Harris KG; Chang EB Clin Sci (Lond); 2018 Sep; 132(18):2013-2028. PubMed ID: 30232239 [TBL] [Abstract][Full Text] [Related]
50. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention. Aleksandrova K; Romero-Mosquera B; Hernandez V Nutrients; 2017 Aug; 9(9):. PubMed ID: 28867793 [TBL] [Abstract][Full Text] [Related]
51. The Gut Microbiome, Its Metabolome, and Their Relationship to Health and Disease. Wu GD Nestle Nutr Inst Workshop Ser; 2016; 84():103-10. PubMed ID: 26764479 [TBL] [Abstract][Full Text] [Related]
52. Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation. Mehta M; Ahmed S; Dryden G Innate Immun; 2017 Aug; 23(6):497-505. PubMed ID: 28770665 [TBL] [Abstract][Full Text] [Related]
53. The Search for Causative Environmental Factors in Inflammatory Bowel Disease. Rogler G; Zeitz J; Biedermann L Dig Dis; 2016; 34 Suppl 1():48-55. PubMed ID: 27548430 [TBL] [Abstract][Full Text] [Related]
54. Mucus sialylation determines intestinal host-commensal homeostasis. Yao Y; Kim G; Shafer S; Chen Z; Kubo S; Ji Y; Luo J; Yang W; Perner SP; Kanellopoulou C; Park AY; Jiang P; Li J; Baris S; Aydiner EK; Ertem D; Mulder DJ; Warner N; Griffiths AM; Topf-Olivestone C; Kori M; Werner L; Ouahed J; Field M; Liu C; Schwarz B; Bosio CM; Ganesan S; Song J; Urlaub H; Oellerich T; Malaker SA; Zheng L; Bertozzi CR; Zhang Y; Matthews H; Montgomery W; Shih HY; Jiang J; Jones M; Baras A; Shuldiner A; Gonzaga-Jauregui C; Snapper SB; Muise AM; Shouval DS; Ozen A; Pan KT; Wu C; Lenardo MJ Cell; 2022 Mar; 185(7):1172-1188.e28. PubMed ID: 35303419 [TBL] [Abstract][Full Text] [Related]
55. Role of commensal gut bacteria in inflammatory bowel diseases. Loh G; Blaut M Gut Microbes; 2012; 3(6):544-55. PubMed ID: 23060017 [TBL] [Abstract][Full Text] [Related]
57. The microbiome of translocated bacterial populations in patients with and without inflammatory bowel disease. Kiely CJ; Pavli P; O'Brien CL Intern Med J; 2018 Nov; 48(11):1346-1354. PubMed ID: 29893034 [TBL] [Abstract][Full Text] [Related]
58. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease. Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835 [TBL] [Abstract][Full Text] [Related]
59. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154 [TBL] [Abstract][Full Text] [Related]